Stay updated on Filgotinib Long-Term Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Long-Term Ulcerative Colitis Clinical Trial page.

Latest updates to the Filgotinib Long-Term Ulcerative Colitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's revision tag was updated to v3.6.3, replacing the previous v3.6.2 tag. This signals an updated page version of the study record.SummaryDifference0.0%

- Check25 days agoChange DetectedThe site revision has been updated from v3.6.0 to v3.6.2. This indicates an underlying software update to the platform hosting the study details.SummaryDifference0.0%

- Check40 days agoChange DetectedAdded several guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated recruitment messaging to indicate no longer looking for participants, clarifying how to engage with the study. The Intervention/Treatment label formatting was refined and the page revision note updated to v3.6.0.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision v3.5.5 is now shown on the page footer. This indicates a new revision tag for the study record without altering substantive content or functionality.SummaryDifference0.0%

- Check54 days agoChange DetectedLocations now includes Pisa, Italy (56124) as a new study site, expanding recruitment options in Italy. The previous Pisa entry has been removed.SummaryDifference0.2%

- Check61 days agoChange DetectedLakefront Biotherapeutics NV is added as a collaborator and Galapagos NV is removed as a collaborator. The page revision is updated from v3.5.3 to v3.5.4 to capture these changes.SummaryDifference0.0%

Stay in the know with updates to Filgotinib Long-Term Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Long-Term Ulcerative Colitis Clinical Trial page.